3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Seroma
1
Rectal Neoplasms
1
Psoriasis
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Parotid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Temozolomide
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiotherapy
4
Radiation
3
trametinib
2
dabrafenib
2
Radiotherapy, Intensity-Modulated
2
Bevacizumab
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
ribociclib
1
Spinal Puncture
1
Protons
1
Proton Therapy
1
Pluvicto
1
Nivolumab
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Flucytosine
1
Everolimus
1
Carboplatin
1
CTLA-4 Antigen
1
AZD1390
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Standard of Care
×
30 days
×
Clear all
No trials found.